L. Klein and K. Jovanovic, Regulatory T cell lineage commitment in the thymus

, Semin Immunol, vol.23, pp.401-409

K. Wing and S. Sakaguchi, Regulatory T cells exert checks and balances on self 588 tolerance and autoimmunity, Nat Immunol, vol.11, pp.7-13

S. F. Ziegler, FOXP3: of mice and men, Annu Rev Immunol, vol.24, pp.209-226, 2006.

Q. Chen, Y. C. Kim, A. Laurence, G. A. Punkosdy, and E. M. Shevach, IL-2 591 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo, J 592 Immunol, vol.186, pp.6329-6337, 2003.

M. A. Curotto-de-lafaille and J. J. Lafaille, Natural and adaptive foxp3+ 594 regulatory T cells: more of the same or a division of labor?, Immunity, vol.30, pp.626-635, 2009.

S. G. Zheng, J. Wang, P. Wang, J. D. Gray, and D. A. Horwitz, IL-2 is essential for 596 TGF-beta to convert naive CD4+CD25-cells to CD25+Foxp3+ regulatory T cells and for 597 expansion of these cells, J Immunol, vol.178, pp.2018-2027, 2007.

A. O'garra and P. Vieira, Regulatory T cells and mechanisms of immune 599 system control, Nat Med, vol.10, pp.801-805, 2004.

C. M. Hawrylowicz and A. O'garra, Potential role of interleukin-10-secreting 601 regulatory T cells in allergy and asthma, Nat Rev Immunol, vol.5, pp.271-283, 2005.

M. G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer et al.,

. Levings, Interleukin-10-secreting type 1 regulatory T cells in rodents and 604 humans, Immunol Rev, vol.212, p.10, 2006.

P. Verginis, K. A. Mclaughlin, K. W. Wucherpfennig, H. Boehmer, and I. ,

. Apostolou, Induction of antigen-specific regulatory T cells in wild-type mice: 607 visualization and targets of suppression, Proc Natl Acad Sci U S A, vol.105, p.11, 2008.

K. Kretschmer, I. Apostolou, D. Hawiger, K. Khazaie, M. C. Nussenzweig et al., , vol.609

. Boehmer, Inducing and expanding regulatory T cell populations by foreign 610 antigen, Nat Immunol, vol.6, p.12, 2005.

I. Apostolou and H. Boehmer, In vivo instruction of suppressor 612 commitment in naive T cells, J Exp Med, vol.199, p.13, 2004.

D. Mucida, N. Kutchukhidze, A. Erazo, M. Russo, J. J. Lafaille et al., , p.614

. Lafaille, Oral tolerance in the absence of naturally occurring Tregs, J Clin Invest, vol.615, p.14, 2005.

M. A. Curotto-de-lafaille, N. Kutchukhidze, S. Shen, Y. Ding, H. Yee et al., Adaptive Foxp3+ regulatory T cell-dependent and -independent control of 618 allergic inflammation, Immunity, vol.617, p.15, 2008.

B. Knoechel, J. Lohr, E. Kahn, J. A. Bluestone, and A. K. Abbas, Sequential 620 development of interleukin 2-dependent effector and regulatory T cells in response 621 to endogenous systemic antigen, J Exp Med, vol.202, p.16, 2005.

D. Haribhai, W. Lin, B. Edwards, J. Ziegelbauer, N. H. Salzman et al., , p.623

P. M. Simpson, T. A. Chatila, and C. B. Williams, A central role for induced 624 regulatory T cells in tolerance induction in experimental colitis, J Immunol, vol.182, p.17, 2009.

M. A. Curotto-de-lafaille, A. C. Lino, N. Kutchukhidze, and J. J. Lafaille, CD25-T 627 cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion, J Immunol, vol.628, p.18, 2004.

M. J. Benson, K. Pino-lagos, M. Rosemblatt, and R. J. Noelle, All-trans retinoic 630 acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face 631 of high levels of co-stimulation, J Exp Med, vol.204, p.19, 2007.

A. J. Edwards and S. L. Pender, Histone deacetylase inhibitors and their potential 633 role in inflammatory bowel diseases, Biochem Soc Trans, vol.39, pp.1092-1095

G. Amodio, A. Mugione, A. M. Sanchez, P. Vigano, M. Candiani et al., , p.635

P. Roncarolo, S. Panina-bordignon, and . Gregori, HLA-G expressing DC-10 and CD4(+) T 636 cells accumulate in human decidua during pregnancy, Hum Immunol, vol.74, p.21

C. C. Gross and H. Wiendl, Dendritic cell vaccination in autoimmune disease, Curr 638 Opin Rheumatol, vol.25, p.22

C. M. Hilkens, J. D. Isaacs, and A. W. Thomson, Development of dendritic cell-640 based immunotherapy for autoimmunity, Int Rev Immunol, vol.29, p.23, 2010.

K. Mahnke, Y. Qian, J. Knop, and A. H. Enk, Induction of CD4+/CD25+ 642 regulatory T cells by targeting of antigens to immature dendritic cells, Blood, vol.643, p.24, 2003.

K. Kretschmer, T. S. Heng, and H. Boehmer, De novo production of 645 antigen-specific suppressor cells in vivo, Nat Protoc, vol.1, p.25, 2006.

J. Idoyaga, C. Fiorese, L. Zbytnuik, A. Lubkin, J. Miller et al., , p.647

R. M. Merad and . Steinman, Specialized role of migratory dendritic cells in peripheral 648 tolerance induction, J Clin Invest, vol.123, p.26

M. Feuerer, J. A. Hill, K. Kretschmer, H. Boehmer, D. Mathis et al., Genomic definition of multiple ex vivo regulatory T cell subphenotypes, Proc 651 Natl Acad Sci, vol.107, p.27, 2010.

H. Jonuleit, E. Schmitt, G. Schuler, J. Knop, and A. H. Enk, Induction of 653 interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties 654 by repetitive stimulation with allogeneic immature human dendritic cells, J Exp Med, vol.655, p.28, 2000.

M. Menges, S. Rossner, C. Voigtlander, H. Schindler, N. A. Kukutsch et al.,

G. Erb, M. B. Schuler, and . Lutz, Repetitive injections of dendritic cells matured 658 with tumor necrosis factor alpha induce antigen-specific protection of mice from 659 autoimmunity, J Exp Med, vol.195, p.29, 2002.

C. Petzold, J. Riewaldt, T. Koenig, S. Schallenberg, and K. Kretschmer, Dendritic cell-661 targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T 662 cells into regulatory T cells and promotes immunotolerance in NOD mice, Rev Diabet, vol.663, p.30

L. M. Charbonnier, L. M. Van-duivenvoorde, F. Apparailly, C. Cantos, W. G. Han et al.,

C. Noel, T. W. Duperray, R. E. Huizinga, C. Toes, P. Jorgensen et al., , 2006.

, Immature dendritic cells suppress collagen-induced arthritis by in vivo expansion of 667 CD49b+ regulatory T cells, J Immunol, vol.177, p.31

C. Huizinga, R. E. Jorgensen, and . Toes, Antigen-specific immunomodulation of 670 collagen-induced arthritis with tumor necrosis factor-stimulated dendritic cells, Arthritis Rheum, vol.671, p.32, 2004.

L. M. Charbonnier, W. G. Han, J. Quentin, T. W. Huizinga, J. Zwerina et al., , p.673

P. Jorgensen and . Louis-plence, Adoptive transfer of IL-10-secreting 674, 2010.

, CD4+CD49b+ regulatory T cells suppresses ongoing arthritis, J Autoimmun, vol.34, p.33

W. G. Han, E. I. Van-der, H. Voort, P. Bannoudi, T. W. Louis-plence et al.,

E. Toes, DX5(+)CD4(+) T cells modulate cytokine production by CD4(+) T cells 678 towards IL-10 via the production of IL-4, Eur J Immunol, vol.40, p.34, 2010.

A. Gonzalez, I. Andre-schmutz, C. Carnaud, D. Mathis, and C. Benoist, Damage 680 control, rather than unresponsiveness, effected by protective DX5+ T cells in 681 autoimmune diabetes, Nat Immunol, vol.2, p.35, 2001.

N. Gagliani, C. F. Magnani, S. Huber, M. E. Gianolini, M. Pala et al., , p.683

D. R. Herbert, A. Bulfone, F. Trentini, C. D. Serio, R. Bacchetta et al.,

S. Brockmann, R. A. Gregori, M. G. Flavell, and . Roncarolo, Coexpression of 685 CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells, Nat Med, vol.686, p.36, 2013.

N. Ohkura, M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka et al.,

R. Tanaka, N. Yamashita, J. Nakano, H. J. Huehn, T. Fehling et al., T cell receptor stimulation-induced epigenetic changes and Foxp3 690 expression are independent and complementary events required for Treg cell 691 development, Immunity, vol.37, p.37

J. A. Hill, M. Feuerer, K. Tash, S. Haxhinasto, J. Perez et al.,

. Benoist, Foxp3 transcription-factor-dependent and -independent regulation of 694 the regulatory T cell transcriptional signature, Immunity, vol.27, p.38, 2007.

P. Chuchana, D. Marchand, M. Nugoli, C. Rodriguez, N. Molinari et al., , p.696

. Sanz, An adaptation of the LMS method to determine expression variations in 697 profiling data, Nucleic Acids Res, vol.35, p.39, 2007.

P. Chuchana, P. Holzmuller, F. Vezilier, D. Berthier, I. Chantal et al.,

G. Lemesre, P. Cuny, B. Nirde, and . Bucheton, Intertwining threshold settings, 700 biological data and database knowledge to optimize the selection of differentially 701 expressed genes from microarray, PLoS One, vol.5, p.40, 2010.

H. Asnagli, D. Martire, N. Belmonte, J. Quentin, H. Bastian et al.,

A. L. Fall, A. Mausset-bonnefont, S. Mantello-moreau, I. Rouquier, and C. Marchetti,

A. Jorgensen, P. Foussat, and . Louis-plence, Type 1 regulatory T cells specific for 705 collagen-type II as an efficient cell-based therapy in arthritis, Arthritis Res Ther, vol.706, p.41, 2014.

L. M. Francisco, V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman et al., PD-L1 regulates the development, maintenance, and function 709 of induced regulatory T cells, J Exp Med, vol.206, p.42, 2009.

D. Bruder, M. Probst-kepper, A. M. Westendorf, R. Geffers, S. Beissert et al., Neuropilin-1: a surface marker of 712 regulatory T cells, Eur J Immunol, vol.34, p.43, 2004.

M. Yadav, C. Louvet, D. Davini, J. M. Gardner, M. Martinez-llordella et al., , p.714

B. A. Bucktrout, F. M. Anthony, R. Sverdrup, D. J. Head, P. Kuster et al., , p.715

D. , V. Schack, and J. A. Bluestone, Neuropilin-1 distinguishes natural and 716 inducible regulatory T cells among regulatory T cell subsets in vivo, J Exp Med, vol.717, pp.1711-1719, 2012.

J. M. Weiss, A. M. Bilate, M. Gobert, Y. Ding, M. A. Curotto-de-lafaille et al., , p.719

H. Parkhurst, J. Xiong, A. B. Dolpady, M. G. Frey, Y. Ruocco et al., , p.720

S. Oh, M. O. Li, R. E. Niec, A. Y. Rudensky, M. L. Dustin et al., Neuropilin 1 is expressed on thymus-derived natural regulatory T cells, but not 722 mucosa-generated induced Foxp3+ T reg cells, J Exp Med, vol.721, pp.1723-1742, 2012.

A. M. Thornton, P. E. Korty, D. Q. Tran, E. A. Wohlfert, P. E. Murray et al.,

M. Shevach, Expression of Helios, an Ikaros transcription factor family member, 725 differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells, J 726 Immunol, vol.184, pp.3433-3441

K. Singh, M. Hjort, L. Thorvaldson, and S. Sandler, Concomitant analysis of Helios and 728

, Neuropilin-1 as a marker to detect thymic derived regulatory T cells in naive mice, Sci, vol.729, p.47

Y. Zheng, A. Chaudhry, A. Kas, P. Deroos, J. M. Kim et al.,

U. Treuting, A. Y. Klein, and . Rudensky, Regulatory T-cell suppressor program 732 co-opts transcription factor IRF4 to control T(H)2 responses, Nature, vol.458, p.48, 2009.

M. A. Koch, G. Tucker-heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl et al.,

. Campbell, The transcription factor T-bet controls regulatory T cell homeostasis 735 and function during type 1 inflammation, Nat Immunol, vol.10, p.49, 2009.

A. Chaudhry, D. Rudra, P. Treuting, R. M. Samstein, Y. Liang et al.,

. Rudensky, CD4+ regulatory T cells control TH17 responses in a Stat3-dependent 738 manner, vol.326, p.50, 2009.

D. J. Campbell and M. A. Koch, Phenotypical and functional specialization of FOXP3+ 740 regulatory T cells, Nat Rev Immunol, vol.11, p.51

E. A. Wohlfert, J. R. Grainger, N. Bouladoux, J. E. Konkel, G. Oldenhove et al., , p.742

J. A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, W. E. Paul et al., , p.743

M. Oukka, J. Zhu, and Y. Belkaid, GATA3 controls Foxp3(+) regulatory T cell fate 744 during inflammation in mice, J Clin Invest, vol.121, p.52

C. Pot, H. Jin, A. Awasthi, S. M. Liu, C. Y. Lai et al.,

I. C. Miaw, V. K. Ho, and . Kuchroo, Cutting edge: IL-27 induces the transcription 747 factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately 748 act together to promote differentiation of IL-10-producing Tr1 cells, J Immunol, vol.749, p.53, 2009.

C. F. Magnani, G. Alberigo, R. Bacchetta, G. Serafini, M. Andreani et al., Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a 752 novel mechanism of suppression by human Tr1 cells, Eur J Immunol, vol.41, p.54, 2011.

R. K. Selvaraj and T. L. Geiger, Mitigation of experimental allergic 754 encephalomyelitis by TGF-beta induced Foxp3+ regulatory T lymphocytes through the 755 induction of anergy and infectious tolerance, J Immunol, vol.180, p.55, 2008.

S. E. Weber, J. Harbertson, E. Godebu, G. A. Mros, R. C. Padrick et al.,

L. M. Ziegler and . Bradley, Adaptive islet-specific regulatory CD4 T cells control 758 autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo, J Immunol, vol.759, pp.4730-4739, 2006.

Q. Zhang, F. Cui, L. Fang, J. Hong, B. Zheng et al., TNF-alpha impairs 761 differentiation and function of TGF-beta-induced Treg cells in autoimmune diseases 762 through Akt and Smad3 signaling pathway, J Mol Cell Biol, vol.5, p.57

V. Brun, V. Neveu, Y. M. Pers, S. Fabre, B. Quatannens et al.,

C. Chossat, A. Jorgensen, and . Foussat, Isolation of functional autologous 765 collagen-II specific IL-10 producing Tr1 cell clones from rheumatoid arthritis blood, Int 766 Immunopharmacol, vol.11, p.58, 2011.

S. Floess, J. Freyer, C. Siewert, U. Baron, S. Olek et al., , p.768

T. Bopp, E. Schmitt, S. Klein-hessling, E. Serfling, A. Hamann et al., , 2007.

, Epigenetic control of the foxp3 locus in regulatory T cells, PLoS Biol, vol.5, p.59

J. K. Polansky, K. Kretschmer, J. Freyer, S. Floess, A. Garbe et al.,

H. Hamann, J. Boehmer, and . Huehn, DNA methylation controls Foxp3 gene 772 expression, Eur J Immunol, vol.38, p.60, 2008.

S. Nadkarni, C. Mauri, and M. R. Ehrenstein, Anti-TNF-alpha therapy induces a 774 distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-775 beta, J Exp Med, vol.204, pp.33-39, 2007.

G. L. Stephens, J. Andersson, and E. M. Shevach, Distinct subsets of FoxP3+ 777 regulatory T cells participate in the control of immune responses, J Immunol, vol.778, p.62, 2007.

L. Apetoh, F. J. Quintana, C. Pot, N. Joller, S. Xiao et al., , p.780

H. L. Weiner and V. K. Kuchroo, The aryl hydrocarbon receptor interacts with c-Maf 781 to promote the differentiation of type 1 regulatory T cells induced by IL-27, Nat 782 Immunol, vol.11, pp.854-861

A. N. Hegazy, M. Peine, C. Helmstetter, I. Panse, A. Frohlich et al.,

D. Pinschewer, A. Radbruch, and M. Lohning, Interferons direct Th2 cell 785 reprogramming to generate a stable GATA-3(+)T-bet(+) cell subset with combined 786 Th2 and Th1 cell functions, Immunity, vol.32, p.64

G. Amodio, M. Comi, D. Tomasoni, M. E. Gianolini, R. Rizzo et al., , p.788

S. Roncarolo and . Gregori, HLA-G expression levels influence the tolerogenic 789 activity of human DC-10, Haematologica, vol.790, p.65, 2015.

I. Suffia, S. K. Reckling, G. Salay, and Y. Belkaid, A role for CD103 in the 791 retention of CD4+CD25+ Treg and control of Leishmania major infection, J Immunol, vol.792, pp.5444-5455, 2005.

K. L. Cepek, S. K. Shaw, C. M. Parker, G. J. Russell, J. S. Morrow et al., , vol.794

. Brenner, Adhesion between epithelial cells and T lymphocytes mediated by E-795 cadherin and the alpha E beta 7 integrin, Nature, vol.372, p.67, 1994.

A. Hanazawa, K. Hayashizaki, K. Shinoda, H. Yagita, K. Okumura et al., , p.797

S. Tani-ichi, K. Ikuta, B. Eckes, A. Radbruch, K. Tokoyoda et al., CD49b-798 dependent establishment of T helper cell memory, canonical markers of CD25 + FoxP3 + Treg cells are, vol.91, p.827

, CD49b + effector memory cells. A, Representative flow cytometry analyses of 828 splenocytes from DC-injected mice (n=18) within the gated CD4 (left), vol.25, p.829

, Quadrants were set as indicated and frequencies 830 observed from days 50 to 59 for CD49b treated mice compared with PBS-injected 896 mice; and from day 59 for CD25 treated mice compared with PBS, and CD49b (right) cell populations